Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days.
The first-ever sleep apnea pill cut breathing episodes by over 50% in Phase 3 trials. Here's the data and when to expect FDA ...
The new treatment could hit the market as early as 2027.
For adults with obstructive sleep apnea (OSA), early nonadherence to continuous positive airway pressure (CPAP) does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results